This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2014
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2014
$625.00
- Research and Development—Research and development spending as a proportion of total sales is at its lowest levels since 1988.
- Demographic Trends—With baby boomers reaching retirement age, the demand for pharmaceutical products will continue to outpace the growth in the economy.
- Provincial Cost Controls—Provincial governments have mandated cost controls for generic drugs and are expected to continue to look for further cost savings, limiting output price growth in the domestic market.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
